Sangphil Oh

1.5k total citations
28 papers, 1.2k citations indexed

About

Sangphil Oh is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology. According to data from OpenAlex, Sangphil Oh has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Cell Biology. Recurrent topics in Sangphil Oh's work include Epigenetics and DNA Methylation (12 papers), Cancer-related gene regulation (10 papers) and Hippo pathway signaling and YAP/TAZ (7 papers). Sangphil Oh is often cited by papers focused on Epigenetics and DNA Methylation (12 papers), Cancer-related gene regulation (10 papers) and Hippo pathway signaling and YAP/TAZ (7 papers). Sangphil Oh collaborates with scholars based in United States, South Korea and China. Sangphil Oh's co-authors include Ralf Janknecht, Sook Shin, Tae‐Dong Kim, Dae‐Sik Lim, Hyun Jung Oh, Dongjun Lee, Hoogeun Song, Stan Lightfoot, William L. Berry and Sean Bong Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Sangphil Oh

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sangphil Oh United States 18 926 267 225 195 169 28 1.2k
Hiu‐Fung Yuen Hong Kong 17 550 0.6× 174 0.7× 122 0.5× 167 0.9× 238 1.4× 23 792
Emily E. Bosco United States 12 654 0.7× 229 0.9× 157 0.7× 207 1.1× 463 2.7× 21 1.1k
Garrett T. Graham United States 17 774 0.8× 412 1.5× 191 0.8× 248 1.3× 355 2.1× 31 1.3k
Katia Coulonval Belgium 20 609 0.7× 175 0.7× 220 1.0× 136 0.7× 456 2.7× 28 1.1k
Tieju Liu China 20 764 0.8× 129 0.5× 133 0.6× 451 2.3× 340 2.0× 38 1.0k
Cindy Hodakoski United States 10 864 0.9× 107 0.4× 113 0.5× 315 1.6× 203 1.2× 11 1.2k
Irene Rodríguez‐Hernández Spain 15 481 0.5× 191 0.7× 76 0.3× 161 0.8× 279 1.7× 21 877
Toshifumi Yae Japan 9 681 0.7× 173 0.6× 135 0.6× 328 1.7× 339 2.0× 18 1.0k
Maren Diepenbruck Switzerland 9 635 0.7× 187 0.7× 93 0.4× 359 1.8× 403 2.4× 13 970
Ayush Dagvadorj United States 19 672 0.7× 243 0.9× 270 1.2× 206 1.1× 448 2.7× 23 1.2k

Countries citing papers authored by Sangphil Oh

Since Specialization
Citations

This map shows the geographic impact of Sangphil Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sangphil Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sangphil Oh more than expected).

Fields of papers citing papers by Sangphil Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sangphil Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sangphil Oh. The network helps show where Sangphil Oh may publish in the future.

Co-authorship network of co-authors of Sangphil Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Sangphil Oh. A scholar is included among the top collaborators of Sangphil Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sangphil Oh. Sangphil Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oh, Sangphil, et al.. (2025). Anti-tumor activity of CDYL2b in prostate cancer. Cancer Letters. 632. 217987–217987.
2.
Oh, Sangphil & Ralf Janknecht. (2024). Versatile JMJD proteins: juggling histones and much more. Trends in Biochemical Sciences. 49(9). 804–818. 6 indexed citations
3.
Mohammed, Sabira, Nidheesh Thadathil, Constantin Georgescu, et al.. (2023). Absence of Either Ripk3 or Mlkl Reduces Incidence of Hepatocellular Carcinoma Independent of Liver Fibrosis. Molecular Cancer Research. 21(9). 933–946. 17 indexed citations
4.
Kim, Tae‐Dong, et al.. (2023). SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A. JCI Insight. 8(20). 3 indexed citations
5.
Kim, Tae‐Dong, et al.. (2023). Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis. Frontiers in Oncology. 13. 1295613–1295613. 3 indexed citations
6.
Sui, Yuan, et al.. (2023). Promotion of colorectal cancer by transcription factor BHLHE40 involves upregulation of ADAM19 and KLF7. Frontiers in Oncology. 13. 1122238–1122238. 11 indexed citations
7.
Sui, Yuan, Xiaomeng Li, Sangphil Oh, et al.. (2020). Opposite Roles of the JMJD1A Interaction Partners MDFI and MDFIC in Colorectal Cancer. Scientific Reports. 10(1). 8710–8710. 22 indexed citations
8.
Oh, Sangphil, Hoogeun Song, Willard M. Freeman, Sook Shin, & Ralf Janknecht. (2020). Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer. International Journal of Oncology. 57(6). 1319–1332. 13 indexed citations
9.
Oh, Sangphil, Sook Shin, & Ralf Janknecht. (2019). The small members of the JMJD protein family: Enzymatic jewels or jinxes?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1871(2). 406–418. 43 indexed citations
10.
Oh, Sangphil, Sook Shin, Hoogeun Song, Joseph P. Grande, & Ralf Janknecht. (2019). Relationship between ETS Transcription Factor ETV1 and TGF-β-regulated SMAD Proteins in Prostate Cancer. Scientific Reports. 9(1). 8186–8186. 23 indexed citations
11.
Oh, Sangphil, et al.. (2018). JMJD5 links CRY1 function and proteasomal degradation. PLoS Biology. 16(11). e2006145–e2006145. 11 indexed citations
12.
Kim, Tae‐Dong, Sangphil Oh, Stan Lightfoot, et al.. (2016). Upregulation of PSMD10 caused by the JMJD2A histone demethylase.. PubMed. 9(6). 10123–10134. 15 indexed citations
13.
Zi, Min, Arfa Maqsood, Sukhpal Prehar, et al.. (2014). The Mammalian Ste20-like Kinase 2 (Mst2) Modulates Stress-induced Cardiac Hypertrophy. Journal of Biological Chemistry. 289(35). 24275–24288. 31 indexed citations
14.
Oh, Sangphil & Ralf Janknecht. (2012). Histone demethylase JMJD5 is essential for embryonic development. Biochemical and Biophysical Research Communications. 420(1). 61–65. 60 indexed citations
15.
Oh, Sangphil, Sook Shin, & Ralf Janknecht. (2012). ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1826(1). 1–12. 208 indexed citations
16.
Kim, Tae‐Dong, Sangphil Oh, Sook Shin, & Ralf Janknecht. (2012). Regulation of Tumor Suppressor p53 and HCT116 Cell Physiology by Histone Demethylase JMJD2D/KDM4D. PLoS ONE. 7(4). e34618–e34618. 65 indexed citations
17.
Lee, Seong Jin, Min Hee Lee, Dong Wook Kim, et al.. (2011). Cross-Regulation between Oncogenic BRAFV600E Kinase and the MST1 Pathway in Papillary Thyroid Carcinoma. PLoS ONE. 6(1). e16180–e16180. 33 indexed citations
18.
Kim, Tae‐Dong, Sook Shin, William L. Berry, Sangphil Oh, & Ralf Janknecht. (2011). The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells. Journal of Cellular Biochemistry. 113(4). 1368–1376. 92 indexed citations
19.
Song, Hoogeun, Sangphil Oh, Hyun Jung Oh, & Dae‐Sik Lim. (2009). Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity. Biochemical and Biophysical Research Communications. 391(1). 969–973. 47 indexed citations
20.
Oh, Sangphil, et al.. (2009). Mst1-FoxO Signaling Protects Naïve T Lymphocytes from Cellular Oxidative Stress in Mice. PLoS ONE. 4(11). e8011–e8011. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiu‐Fung Yuen Breakdown of academic impact, for papers by Emily E. Bosco Breakdown of academic impact, for papers by Garrett T. Graham Breakdown of academic impact, for papers by Katia Coulonval Breakdown of academic impact, for papers by Tieju Liu Breakdown of academic impact, for papers by Cindy Hodakoski Breakdown of academic impact, for papers by Irene Rodríguez‐Hernández Breakdown of academic impact, for papers by Toshifumi Yae Breakdown of academic impact, for papers by Maren Diepenbruck Breakdown of academic impact, for papers by Ayush Dagvadorj
Rankless by CCL
2026